COLOPLAST AS SP/ADR (CLPBY) Stock Price, Quote & AI Analysis

Live CLPBY stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for COLOPLAST AS SP/ADR.

TradeVae provides AI-driven analysis and real-time market intelligence for COLOPLAST AS SP/ADR (CLPBY), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.

C
CLPBY
COLOPLAST AS SP/ADR
real-time
$0.00 +0.00 (+0.00%)
Open
6.200000
High
6.270000
Low
6.120000
Volume
272,078
VWAP
-
52W Range
$6.10 - $10.03
P/E Ratio
-
EPS
-
Dividend Yield
347.30%
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

COLOPLAST AS SP/ADR's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

COLOPLAST AS SP/ADR Overview

Company information

Company Overview

Coloplast A/S engages in the developing, manufacture, and markets medical products. It operates through the following segments: Chronic Care, Voice and Respiratory Care, Interventional Urology, Advanced Wound Dressings, and Biologics. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Voice and Respiratory Care segment refers to the sale of laryngectomy and tracheostomy products. The Interventional Urology segment includes the sale of urological products, including disposable products. The Advanced Wound Dressings segment focuses on the sale of wound and skin care products. The Biologics segment represents a new segment covering the sale of tissue-based products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark. CLPBY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Company Details
Market Cap
$13.99B
Shares Outstanding
2,282,388,067
CEO
Lars Søren Rasmussen
Exchange
OTC Link

Technical Indicators

Key technical analysis metrics and indicators

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

COLOPLAST AS SP/ADR Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...